Recap: Precigen Q4 Earnings
Recap: Precigen Q4 Earnings
Shares of Precigen (NASDAQ:PGEN) decreased in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 15.38% over the past year to ($0.22), which missed the estimate of ($0.17).
Revenue of $19,333,000 rose by 13.71% year over year, which beat the estimate of $16,960,000.
Outlook
Precigen hasn't issued any earnings guidance for the time being.
Precigen hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Mar 01, 2021
Time: 04:30 PM
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/876/40135
Technicals
52-week high: $11.10
52-week low: $1.26
Price action over last quarter: Up 33.33%
Company Profile
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Shares of Precigen (NASDAQ:PGEN) decreased in after-market trading after the company reported Q4 results.
的股份早孕症(納斯達克:PGEN)在該公司公佈第四季度業績後,盤後交易減少。
Quarterly Results
季度業績
Earnings per share increased 15.38% over the past year to ($0.22), which missed the estimate of ($0.17).
過去一年每股獲利增長15.38%至0.22美元,低於預估的0.17美元。
Revenue of $19,333,000 rose by 13.71% year over year, which beat the estimate of $16,960,000.
營收為1933.3萬美元,同比增長13.71%,超過預期的1696萬美元。
Outlook
展望
Precigen hasn't issued any earnings guidance for the time being.
Precigen暫時沒有發佈任何盈利指引。
Precigen hasn't issued any revenue guidance for the time being.
Precigen暫時沒有發佈任何收入指引。
Conference Call Details
電話會議詳細信息
Date: Mar 01, 2021
日期:2021年3月1日
Time: 04:30 PM
時間:下午4時30分
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/876/40135
Technicals
技術細節
52-week high: $11.10
52周高點:11.10美元
52-week low: $1.26
52周低點:1.26美元
Price action over last quarter: Up 33.33%
上季度價格走勢:上漲33.33%
Company Profile
公司簡介
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Precigen Inc是一家開發合成生物學解決方案的生物技術公司。該公司設計、構建和管理基因程序。其技術廣泛適用於各種不同的終端市場。Intrexon的商業模式是通過與擁有特定行業專業知識、開發資源以及銷售和營銷能力的合作者進行獨家渠道合作,將其技術商業化,以便將新的和改進的產品和流程推向市場。該公司的合作者通過技術訪問費、版税、里程碑和某些費用的報銷來提供補償。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧